{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:05:39Z","timestamp":1790849139619,"version":"4.1.0"},"reference-count":23,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T00:00:00Z","timestamp":1624060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Chicago Diabetes Research and Training Center US Public Health Service Grant","award":["P30DK020595"],"award-info":[{"award-number":["P30DK020595"]}]},{"name":"Dompe Pharmaceutical","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>(1) Background: The correlation between titers of islet autoantibodies (IAbs) and the loss of transplanted islets remains controversial. We sought to evaluate the prognostic utility of monitoring IAbs in diabetic patients after islet transplantation (ITx); (2) Methods: Twelve patients with Type 1 diabetes mellitus and severe hypoglycemia underwent ITx. Serum concentration of glutamic acid decarboxylase (GAD), insulinoma antigen 2 (IA-2), and zinc transport 8 (ZnT8) autoantibodies was assessed before ITx and 0, 7, and 75 days and every 3 months post-operatively; (3) Results: IA-2A (IA-2 antibody) and ZnT8A (ZnT8 antibody) levels were not detectable before or after ITx in all patients (median follow-up of 53 months (range 24\u201361)). Prior to ITx, GAD antibody (GADA) was undetectable in 67% (8\/12) of patients. Of those, 75% (6\/8) converted to GADA+ after ITx. In 67% (4\/6) of patients with GADA+ seroconversion, GADA level peaked within 3 months after ITx and subsequently declined. All patients with GADA+ seroconversion maintained long-term partial or complete islet function (insulin independence) after 1 or 2 ITx. There was no correlation between the presence of IAb-associated HLA haplotypes and the presence of IAbs before or after ITx; (4) Conclusions: There is no association between serum GADA trends and ITx outcomes. IA-2A and ZnT8A were not detectable in any of our patients before or after ITx.<\/jats:p>","DOI":"10.3390\/jcm10122708","type":"journal-article","created":{"date-parts":[[2021,6,20]],"date-time":"2021-06-20T22:00:02Z","timestamp":1624226402000},"page":"2708","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluating the Prognostic Value of Islet Autoantibody Monitoring in Islet Transplant Recipients with Long-Standing Type 1 Diabetes Mellitus"],"prefix":"10.3390","volume":"10","author":[{"given":"Roi","family":"Anteby","sequence":"first","affiliation":[{"name":"Department of Surgery, The University of Chicago, Chicago, IL 60637, USA"},{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel"},{"name":"Harvard School of Public Health, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Lucander","sequence":"additional","affiliation":[{"name":"Department of Surgery, The University of Chicago, Chicago, IL 60637, USA"},{"name":"Department of Surgery, University of Alabama at Birmingham, Birmingham, AL 35233, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7694-1793","authenticated-orcid":false,"given":"Piotr J.","family":"Bachul","sequence":"additional","affiliation":[{"name":"Department of Surgery, The University of Chicago, Chicago, IL 60637, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2833-3953","authenticated-orcid":false,"given":"Jordan","family":"Pyda","sequence":"additional","affiliation":[{"name":"Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Grybowski","sequence":"additional","affiliation":[{"name":"Department of Surgery, The University of Chicago, Chicago, IL 60637, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Basto","sequence":"additional","affiliation":[{"name":"Department of Surgery, The University of Chicago, Chicago, IL 60637, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela S.","family":"Generette","sequence":"additional","affiliation":[{"name":"Department of Surgery, The University of Chicago, Chicago, IL 60637, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurencia","family":"Perea","sequence":"additional","affiliation":[{"name":"Department of Surgery, The University of Chicago, Chicago, IL 60637, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2157-8763","authenticated-orcid":false,"given":"Karolina","family":"Golab","sequence":"additional","affiliation":[{"name":"Department of Surgery, The University of Chicago, Chicago, IL 60637, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-jia","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Surgery, The University of Chicago, Chicago, IL 60637, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Tibudan","sequence":"additional","affiliation":[{"name":"Department of Surgery, The University of Chicago, Chicago, IL 60637, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Chicago, Chicago, IL 60637, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Fung","sequence":"additional","affiliation":[{"name":"Department of Surgery, The University of Chicago, Chicago, IL 60637, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Witkowski","sequence":"additional","affiliation":[{"name":"Department of Surgery, The University of Chicago, Chicago, IL 60637, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1464-5491.2006.01796.x","article-title":"The social and economic consequences of childhood-onset Type 1 diabetes mellitus across the life course: A systematic review","volume":"23","author":"Milton","year":"2006","journal-title":"Diabet. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/MED.0000000000000348","article-title":"T1D Autoantibodies: Room for improvement?","volume":"24","author":"Yu","year":"2017","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1900\/RDS.2005.2.121","article-title":"B cells in autoimmune diabetes","volume":"2","author":"Wong","year":"2005","journal-title":"Rev. Diabet. Stud."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2337\/dc15-1419","article-title":"Staging presymptomatic type 1 diabetes: A scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association","volume":"38","author":"Insel","year":"2015","journal-title":"Diabetes Care"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11892-016-0738-2","article-title":"Islet Autoantibodies","volume":"16","author":"Lampasona","year":"2016","journal-title":"Curr. Diabetes Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5500\/wjt.v4.i3.183","article-title":"Autoimmune Diabetes Recurrence Should be Routinely Monitored After Pancreas Transplantation","volume":"4","author":"Martins","year":"2014","journal-title":"World J. Transpl."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2217\/dmt.10.21","article-title":"Recurrence of Autoimmunity in Pancreas Transplant Patients: Research Update","volume":"1","author":"Pugliese","year":"2011","journal-title":"Diabetes Manag."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.2337\/db12-1258","article-title":"Alloantibody and Autoantibody Monitoring Predicts Islet Transplantation Outcome in Human Type 1 Diabetes","volume":"62","author":"Piemonti","year":"2013","journal-title":"Diabetes"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s11892-013-0399-3","article-title":"Immune Monitoring of Islet and Pancreas Transplant Recipients","volume":"13","author":"Abreu","year":"2013","journal-title":"Curr. Diabetes Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2337\/diab.38.1.S82","article-title":"Islet Cell Autoimmunity in Type 1 Diabetic Patients After HLA-mismatched Pancreas Transplantation","volume":"38","author":"Bosi","year":"1989","journal-title":"Diabetes"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2337\/db09-0498","article-title":"Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells","volume":"59","author":"Vendrame","year":"2010","journal-title":"Diabetes"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/ajt.13426","article-title":"Risk Factors for Type 1 Diabetes Recurrence in Immunosuppressed Recipients of Simultaneous Pancreas-Kidney Transplant","volume":"16","author":"Vendrame","year":"2015","journal-title":"Am. J. Transplant."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.2337\/diabetes.50.11.2464","article-title":"Autoantibody response to islet transplantation in type 1 diabetes","volume":"50","author":"Bosi","year":"2001","journal-title":"Diabetes"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.transproceed.2020.02.035","article-title":"Impact of Pancreatic Autoantibodies in Pancreas Graft Survival After Pancreas-Kidney Transplantation","volume":"52","author":"Pestana","year":"2020","journal-title":"Transplant. Proc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2337\/diabetes.48.3.484","article-title":"Auto- and Alloimmune Reactivity to Human Islet Allografts Transplanted Into Type 1 Diabetic Patients","volume":"48","author":"Roep","year":"1999","journal-title":"Diabetes"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.2337\/db09-0160","article-title":"Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients","volume":"58","author":"Hilbrands","year":"2009","journal-title":"Diabetes"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Huurman, V.A., Hilbrands, R., Pinkse, G.G., Gillard, P., Duinkerken, G., Van de Linde, P., van der Meer-Prins, P.M.W., Versteeg-van der Voort Maarschalk, M.F.J., Verbeeck, K., and Alizadeh, B.Z. (2008). Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell Transplantation. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0002435"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/MOT.0b013e32834c2393","article-title":"Control of instant blood-mediated inflammatory reaction to improve islets of Langerhans engraftment","volume":"16","author":"Nilsson","year":"2011","journal-title":"Curr. Opin. Organ Transplant."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/09636897211001774","article-title":"Post-hoc Analysis of a Randomized, Double Blind, Prospective Study: More Standardizations in the Trial Protocol are Needed to Evaluate the Effect of a CXCR1\/2 Blocker in Islet Allotransplantation","volume":"30","author":"Bachul","year":"2021","journal-title":"Cell Transplant."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2337\/dc19-1480","article-title":"REP0211 Targeting CXCR1\/2 Does Not Improve Insulin Secretion After Pancreatic Islet Transplantation: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in Type 1 Diabetes. REP0211 Study Group","volume":"43","author":"Maffi","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-immunol-030409-101323","article-title":"HMGB1 is a therapeutic target for sterile inflammation and infection","volume":"29","author":"Andersson","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Xu, X., Shi, Y., Cai, Y., Zhang, Q., Yang, F., Chen, H., Gu, Y., Zhang, M., Yu, L., and Yang, T. (2013). Inhibition of increased circulating Tfh cell by anti-CD20 monoclonal antibody in patients with type 1 diabetes. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0079858"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1096\/fj.201901637R","article-title":"Follicular helper T cells in type 1 diabetes","volume":"34","author":"Shao","year":"2020","journal-title":"FASEB J."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/12\/2708\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:19:09Z","timestamp":1760163549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/12\/2708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,19]]},"references-count":23,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["jcm10122708"],"URL":"https:\/\/doi.org\/10.3390\/jcm10122708","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,19]]}}}